Company profile for Rubius Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Rubius Therapeutics, a 2017 “Fierce 15” award winner, is creating RCTs as an innovative new class of cellular therapies which address a wide array of diseases and disorders. The company’s lead programs include cancer, enzyme replacement therapy and tolerance induction. Rubius was conceived and launched by Flagship VentureLabs , the institutional innovation foundry where a team of scientific entrepreneurs systematically...
Rubius Therapeutics, a 2017 “Fierce 15” award winner, is creating RCTs as an innovative new class of cellular therapies which address a wide array of diseases and disorders. The company’s lead programs include cancer, enzyme replacement therapy and tolerance induction. Rubius was conceived and launched by Flagship VentureLabs , the institutional innovation foundry where a team of scientific entrepreneurs systematically evolves enterprising ideas into new fields, or previously undiscovered areas of science into real-world inventions and ventures.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
325 Vassar Street, Suite 1A, Cambridge, MA 02139,
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://endpts.com/university-of-bristol-spinout-scarlet-raises-seed-round-for-therapeutic-red-blood-cells/

Amber Tong ENDPTS
23 May 2023

https://endpts.com/incyte-names-ex-rubius-ceo-pablo-cagnoni-as-president-head-of-rd/

Amber Tong ENDPTS
08 May 2023
After last-ditch effort, Rubius moves to dissolve
After last-ditch effort, Rubius moves to dissolve

22 Feb 2023

// Annalee Armstrong FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/after-last-ditch-effort-cellular-medicine-biotech-rubius-moves-dissolve

Annalee Armstrong FIERCE BIOTECH
22 Feb 2023

https://endpts.com/ex-rubius-ceo-dusts-himself-off-at-a-different-flagship-biotech-hutchmed-switches-things-up-during-pipeline-refocus/

Alex Hoffman ENDPTS
18 Nov 2022

https://www.biopharmadive.com/news/laronde-ceo-cagnoni-rubius-flagship/636857/

BIOPHARMADIVE
17 Nov 2022

https://www.globenewswire.com/news-release/2022/11/02/2546990/0/en/Rubius-Therapeutics-Announces-Process-to-Explore-Strategic-Alternatives-and-Leadership-Changes.html

GLOBENEWSWIRE
02 Nov 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty